CORRIGENDUM: Antithrombotic Therapy for Patients With Atrial Fibrillation and Bioprosthetic Valves - Real-World Data From the Multicenter, Prospective, Observational BPV-AF Registry

Circ J. 2024;88(9):1598-1602. doi: 10.1253/circj.CJ-66-0228.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Atrial Fibrillation* / drug therapy
  • Bioprosthesis*
  • Fibrinolytic Agents* / administration & dosage
  • Fibrinolytic Agents* / therapeutic use
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valve Prosthesis Implantation / instrumentation
  • Heart Valve Prosthesis* / adverse effects
  • Humans
  • Prospective Studies
  • Registries*

Substances

  • Fibrinolytic Agents